复发性尿路感染的细菌检验药敏情况及治疗效果观察

Observation of Drug Sensitivity and Therapeutic Effect of Bacteriological Test for Recurrent Urinary Tract Infection

目的探讨复发性尿路感染的细菌检验药敏情况及治疗效果。方法选取我院2017年1月~2018年3月复发性尿路感染患者79例,对其尿液标本实施细菌培养和药敏试验,并根据试验结果对患者进行针对性治疗,分析病原菌情况、药敏试验结果及治疗效果。结果经尿细菌培养,79例患者中尿检阳性29例,其中大肠埃希菌占68.97%,肺炎克雷伯菌占10.34%,粪肠球菌占20.69%,合并支原体感染占17.24%;治疗总有效率为96.20%,且尿检阳性患者治疗效果与阴性患者比较,差异无统计学意义(P>0.05)。结论根据细菌检验药敏结果对复发性尿路感染患者进行针对性抗菌药物治疗,可获得较高的治疗效果。

Objective To investigate the susceptibility and therapeutic effect of bacteriological test for recurrent urinary tract infection.Methods 79 patients with recurrent urinary tract infections from January 2017 to March 2018 were selected and their urine samples were cultured and tested for drug sensitivity.According to the test results,the patients were given targeted treatment,and the pathogenic bacteria,drug sensitivity test results and therapeutic effect were analyzed.Results 29 of the 79 patients were positive in urine culture,of which 68.97% were Escherichia coli,10.34% were Klebsiella pneumoniae,20.69% were Enterococcus faecalis,17.24% were complicated with Mycoplasma infection,and the total effective rate was 96.20%.There was no significant difference in the treatment effect between the positive and negative patients（P〉0.05）.Conclusion According to the results of bacteriological susceptibility test,targeted antimicrobial treatment for patients with recurrent urinary tract infection can obtain a higher therapeutic effect.